DELIA BRAZZELL: Open Payments
NPI 1710465315 · STUART, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,657 in 20 payments from 9 companies in 2025. Trend: 2023 $643 · 2024 $1,986 · 2025 $1,657
Food & beverage: $1,657
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 6 | $462 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $273 |
| Phathom Pharmaceuticals, Inc. | 2 | $248 |
| Ipsen Biopharmaceuticals, Inc | 1 | $150 |
| ABBVIE INC. | 4 | $136 |
| Ardelyx, Inc. | 1 | $125 |
| Gilead Sciences, Inc. | 1 | $119 |
| Janssen Biotech, Inc. | 1 | $117 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
Products named: REZDIFFRA, XIFAXAN, VOQUEZNA, IQIRVO, RINVOQ, IBSRELA, Livdelzi, TREMFYA.
Industry payments across FL — which companies pay providers there.
